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Abstract 
Environmental factors likely regulate neonatal immunity and self-tolerance. However, evi-
dence that the neonatal immune system is suppressed or deviated is varied depending on the 
antigen and the timing of antigen exposure relative to birth. These disparate findings may be 
related to the availability of the appropriate antigen presenting cells but also point to the 
possibility of homeostatic changes in non-lymphoid cells in the relevant lymphoid tissues. 
Here we show that, while leukocytes are the most abundant cell population present in spleen 
during the first 4-5 days after birth, a massive accumulation of nucleated immature erythroid 
population in the spleen takes places on day 6 after birth. Although the relative frequency of 
these immature erythorid cells slowly decreases during the development of neonates, they 
remain one of the most predominant populations up to three weeks of age. Importantly, we 
show that the immature erythroid cells from neonate spleen have the capacity to modulate 
the differentiation of CD4 T cells into effector cells and provide a bias towards a Th2 type 
instead of Th1 type. These nucleated erythroid cells can produce cytokines that participate in 
the Th2/Th1 balance, an important one being IL-6. Thus, the selective accumulation of im-
mature erythroid cells in the spleen during a specific period of neonatal development may 
explain the apparent differences observed in the type(s) of immune responses generated in 
infants and neonates. These findings are potentially relevant to the better management of 
immune deficiency in and to the design of vaccination strategies for the young. 
Key words: Neonatal immunity, erythrocytes, T lymphocytes. 
Introduction 
Although  the  global  mortality  rate  has  fallen, 
nearly eight million children under five die each year, 
and the two biggest killers of these children are infec-
tious diseases [1]. The cost of hospitalization for in-
fected infants in the United States alone is estimated at 
690 million dollars annually [2]. While most vaccines 
do induce protective immunity in older children and 
adults, their efficacy in the very young often requires 
further  manipulation  and  optimization.  This  im-
portant  clinical  phenomenon  suggests  that  further 
examination of the immune physiology of the young 
is required. 
Since the articulation of Lederberg’s [3] immune 
theory, common thinking is that the immune response 
in  neonates  differs  from  that  found  in  adults.  Alt-
hough  evidence  exists  to  support  this  idea  the  un-
derlying  mechanism(s)  remain  unclear.  Initially,  it 
was thought that neonatal T cells were intrinsically 
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deficient (e.g. prone to apoptosis) [4]. However, there 
exist  studies  [5]  which  show  that  by  supplying  the 
correct  form  of  antigen  presentation  (e.g.  activated 
dendritic cells) neonatal mice could produce effective 
immune responses even to minor antigens. More re-
cently [6] it was found that DNA vaccination of neo-
nates produced good immunity to Lymphocytic cho-
riomeningits virus (LCMV). Concurrent with the de-
velopment  of  ideas  about  the  relevance  of  the  type 
(i.e., Th1,Th2,) of immune response [7], studies were 
generated suggesting that neonates were able to re-
spond to antigen, but with a Th2-type bias [8-10]. A 
review of the literature with a focus on the timing of 
antigen exposure reveals that there are studies indi-
cating  that  administration  within  the  first  24  hours 
after birth tends to produce Th1 type of immune re-
sponses [5, 6, 11-17]. However, primary exposure to 
antigen when neonates are 5 days to two weeks old 
leads to a predominant Th2-type of immune response 
[9],[18].  The  Th2  bias  was  observed  primarily  in 
spleen, but not lymph nodes [16]. With the advent of 
the  Th17  response  in  common  immunological  dia-
logue [19], it has also been suggested that there are 
times, at least in early postnatal human development 
where this type of response might be either enhanced 
or suppressed [20]. Together these studies appear to 
indicate that the timing of exposure during neonatal 
development as well as the route of exposure is es-
sential for determining the type of immune response 
in neonates. 
 In this study we identify an unusual cell type 
that massively accumulates in the spleen of neonates 
several days after birth. We show that nucleated im-
mature  erythroid  cells  represent  the  predominant 
population of the spleen of neonates starting from day 
6. These cells have the capacity to secrete specific cy-
tokines (e.g. IL-6) and can modulate differentiation of 
CD4 T cells to favor the development of a Th2 type of 
immune  response.  Thus,  the  presence  of  immature 
erythroid cells in the spleen during a specific period of 
neonatal development could have implications in the 
immune response to infections or immunizations.  
Materials and Methods 
Mice and tissues 
Animals were used in accordance with the In-
stitutional Animal Care and Use Committee (IACUC) 
at the University of Vermont. Eight to ten week old 
C57BL/6 (B6) mice were purchased from The Jackson 
Laboratory (Bar Harbor, ME) and maintained under 
specific pathogen free conditions at the University of 
Vermont. The  mice  underwent a timed  mating and 
observed for delivery of a litter. The morning after a 
litter delivered was considered day one of postnatal 
life. At 2 through 42 days of life the pups were eu-
thanized  and  their  spleen  used  for  the  studies  de-
scribed. Mice at 21 days of postnatal life were weaned. 
Flow cytometry 
In  order  to  identify  specific  erythroid  and  im-
mune cell populations by flow cytometry we used a 
panel  of  monoclonal  antibodies  against  cell  surface 
proteins  that  are  generally  accepted  to  characterize 
each cellular subset. Erythroid precursors were dis-
tinguished by the presence of the lymphocyte antigen 
76 (LY-76, TER-119) molecule, which is found on the 
red cell surface from the pro-erythroblast to the ma-
ture erythrocyte stage [21]. Throughout development 
B lymphocytes selectively express the protein tyrosine 
phosphatase receptor type C (PTPRC, B220) protein, a 
glycosylated high molecular weight splice variant of 
the common leukocyte antigen [22, 23]. The T cell re-
ceptor beta chain (TCRB) is one component of the T 
cell  antigen  receptor  signaling  complex  [24]  that  is 
expressed exclusively on the surface of alpha/beta T 
lymphocytes    [25].  The  lymphocyte  antigen  6  com-
plex, locus G (LY-6G, GR1) protein is expressed pre-
dominantly  by  neutrophils  in  peripheral  tissues  as 
well as on the cell surface of granulocytes in the bone 
marrow [26]. Cells of the monocyte/macrophage lin-
eage  can  be  characterized  by  expression  of  integrin 
alpha M (ITGAM, CD11b)  [27]. Tissue resident mac-
rophages  in  the  spleen  that  are  CD11b  positive  ex-
press  genes  involved  in  chemotaxis  and  bacterial 
degradation,  while  CD11b  negative  cells  express 
genes  involved  in  phagocytosis  and  iron  recycling  
[28]. Monoclonal  antibodies  against  these  cell  types 
were obtained from eBioscience, Inc., San Diego, CA 
and BD Biosciences, San Jose, CA. 
Quantitative PCR 
Total RNA was extracted from sorted cell sam-
ples  using  Triazol  (Invitrogen)  per  manufacture's 
guidelines.  RNA  samples  were  tested  for  integrity 
using the Agilent Bioanalyzer (Agilent Technologies). 
All samples were quantified by UV absorbance at 260 
nm  on  a  nanodrop  spectrophotometer  (NanoDrop, 
ThermoScientific,  Willmington,  DE).  Real  time 
RT-PCR studies were  performed in a two-step pro-
cess. The iScript cDNA synthesis kit (Bio-Rad Labor-
atories, Hercules, CA) was used to synthesize cDNA 
from 250ng (T-cells), or 750ng (Terr119 cells) of RNA 
template using a mix of random hexamers and oligo 
dts. For each sample the cDNA was used to amplify 
the target genes, including cytokines interleukins-2, 4, 
6 and interferon-. In addition, primer sets were de-
signed to determine the expression of the hemoglobin Int. J. Biol. Sci. 2012, 8 
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adult major chain (Hbb-b1) [29] and the hemoglobin Z, 
beta-like  embryonic  chain  (Hbb-bh1)  [30]  as  an  esti-
mate of the relative expression of adult and fetal he-
moglobin  by  Ter119+  cells.  The  expression  of  two 
housekeeping  genes  hypoxanthine  guanine  phos-
phoribosyl  transferase  1  (Hprt1)  and  tyrosine 
3-monooxygenase/  tryptophan  5-monooxygenase 
activation protein, zeta polypeptide (Ywhaz) was also 
included  in  these  studies.  One  microliter  of  cDNA 
was used per reaction with 150nM of the forward and 
reverse  primers  (see  table  1),  and  12.5ul  of  Power 
Sybrgreen Master Mix (Applied Biosystems) in a 25µl 
reaction.  The  reactions  were  performed  on  an  ABI 
Prism 7000 (Applied Biosystems) using an initial de-
naturation of 10 minutes at 95°C, 40 cycles of 15 se-
conds at 95°C and 60 seconds at 60°C, followed by a 
melt curve analysis to ensure only the correct product 
was amplified. Standard curves were generated for all 
the target  genes as  well as the  housekeeping  genes 
using a single sample which was serially diluted over 
the working range of the assay. Using these standard 
curves  the  relative  quantities  of  each  sample  were 
determined. Relative target mRNA values were nor-
malized by dividing the target quantity by the geo-
metric  mean  of  the  quantities  of  the  housekeeping 
genes.  Each  sample  was  run  in  triplicate  and  aver-
aged. Negative water controls were run for each pri-
mer  set  in  the  real  time  PCR  reaction  to  ensure  no 
contamination in the reagents as well as no secondary 
primer structures were amplified. In each primer set 
at least one primer was designed over an exon-exon 
junction  or  if  that  was  not  possible,  the  primers 
spanned an intron region. The specific primers used 
are seen in Table 1. 
Cell culture 
CD4+ T cells from lymph nodes and spleens were 
isolated by negative selection, as previously described 
depleting cells expressing CD8, CD11b, MHC class II, 
and  NK1.1  [31].  CD4+  T  cells  were  activated  with 
plate-bound 5 µg/ml anti-CD3 (2C11) and 1 µg/ml of 
soluble anti-CD28 (BD) mAbs in Bruff's medium in 
the  presence  or  absence  of  different  amounts  of 
Ter119+  cells.  Ter119+  cells  were  purified  using  a 
magnetic bead system as per the manufacturer’s in-
structions (Miltenyi, Auburn CA). 
ELISA 
ELISAs were performed as previously described  
[32] with purified anti-IL-2, anti-IFN, anti–IL-4 and 
anti-IL-6 mAb (2 μg/ml) as capture antibody. For the 
revelation  step  the  corresponding  biotinylated  an-
ti–IL-4,  anti-IL-2,  anti-IFN  and  anti-IL-6  mAb  (1 
μg/ml; BD PharMingen), were used with horseradish 
peroxidase-conjugated  streptavidin  (Sigma-Aldrich), 
and  TMB  microwell  peroxidase  substrate  and  stop 
solution (Kirkegaard & Perry Labs, Inc.) according to 
the manufacturer’s instruction (BD PharMingen). 
 
Table 1. Primers used for the Quantitative PCR studies described. 
Name  Sequence  Product size 
Hbb-bh1(fetal hgb)_Forward  GTTAAGAACATGGACAACCTCAAGGA  127 
Hbb-bh1_Reverse  GAGTAGAAAGGACAATCACCAACATG    
Hbb-b1(adult hgb)_F  ACGCCGATGAAGTTGGTGGT  110 
Hbb-b1_R  CATGATAGCAGAGGCAGAGGATAGG    
IL2_F  CCCAGGATGCTCACCTTCAAATT  96 
IL2_R  ATGCCGCAGAGGTCCAAGTT    
IL4_F  CCACGGATGCGACAAAAATCA  157 
IL4_R  CACCTTGGAAGCCCTACAGAC    
IL6_F  AGAAAGACAAAGCCAGAGTCCTTCAG  157 
IL6_R  GTCCTTAGCCACTCCTTCTGTGACT    
Ifn_F  CCTCATGGCTGTTTCTGGCTGTTA  359 
Ifn_R  CATTGAATGCTTGGCGCTGGACC    
Hprt_F  CAGTCCCAGCGTCGTGAT  137 
Hprt_R  CAAGTCTTTCAGTCCTGTCCATAA    
Ywhaz_F  GCA ACG ATG TAC TGT CTC TTT TGG   149 
Ywhaz_R  GTCCACAATTCCTTTCTTGTCATC    Int. J. Biol. Sci. 2012, 8 
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Results 
Selective accumulation of immature erythro-
blasts in the spleen from neonates acquired 
after birth  
 Although it is believed that spleen cellularity in 
neonates is different from that in adults, no studies 
have  completely  characterized  the  populations  pre-
sent  during  maturation  in  the  neonatal  period.  We 
therefore examined neonatal spleen cells by flow cy-
tometry. The presence of leukocytes (i.e. lymphocytes, 
macrophages,  granulocytes,  dendritic  cells,  natural 
killer cells and others) was determined by detecting 
the expression of the pan-leukocyte marker CD45. The 
majority of cells in spleen of day-2 neonates (Figure 
1A)  were  CD45+  cells.  Interestingly,  however,  the 
proportion of CD45+ spleen cells drastically dropped 
by day 6 and remained low during most of the neo-
natal stage. It slowly increased again by day 15 after 
birth. The non-leukocyte population that emerged 6 
days  after  birth  and  accumulated  in  the  spleen  ex-
pressed  CD44,  although  at  lower  levels  than  most 
leukocytes  (Figure  1A).  To  initiate  the  characteriza-
tion of this non-leukocyte population of cells present 
in  the  neonatal  spleen,  we  performed  histological 
analysis by Giemsa staining of cytospun cells from the 
spleen of adult mice or day-8 and day-17 neonates. As 
expected, in adult spleen almost all cells were small, 
displayed a condense nucleus that occupied most of 
their cell content, and have minimal cytoplasm con-
tent  (Figure  1B).  In  contrast,  the  spleen  cells  from 
day-8 neonates were substantially larger, with less a 
condensed  nucleus  and  increased  cytoplasmic  area 
suggestive of early hematopoietic progenitors present 
in  bone  marrow.  Consistent  with  the  presence  of 
non-leukocyte cells observed by flow analysis, these 
large cells remained in the spleen of day-17 neonates, 
although  their  frequency  was  observed  to  be  much 
lower than at day 8 (Figure 1B).  
 
Figure 1. Presence of a non-lymphoid population of cells in neonatal spleen after 6 days of birth. A. Flow cytometric 
analysis of CD44 and CD45 in spleens from adult mice and neonates at different periods of time after birth. Numbers represent the 
percentage of cells in each quadrant. B. Giemsa staining of cytospun spleen cells from adult mice and day-8 and day-17 neonates. Arrows 
point to large cells with less condensed nuclei. Data shown are representative of three experiments. Int. J. Biol. Sci. 2012, 8 
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Figure 2. Phenotype of Ter119+ immature erythroid cells in neonatal spleen. A. Flow cytometry analysis for Sca1, C-kit, B220 
and CD34 in spleen from day-7 neonates. Numbers represent the percentage of cells in each quadrant. B. Flow cytometry analysis for 
Ter119 together with CD45, Ly6G/C (Gr1), CD11b, B220 and TCR. Numbers represent the percentage in each gated population. Data 
from A and B are representative of three experiments. C. Expression of fetal and adult hemoglobin in Ter119+ cells isolated from the liver 
of three day-17 fetuses (fetal liver) and from spleens of three day-6 neonates (neonatal spleen) by RT-PCR using total RNA. Values are 
expressed as fold induction relative to the expression in fetal liver Ter119 cells. 
 
 This atypical population of large cells was not 
abundant for the first 3-4 days after birth (data not 
shown) arguing that they were not fetal-derived early 
progenitors. Nevertheless, we examined whether they 
could  be  hematopoietic  stem  cells  migrating  from 
bone marrow. No CD34+ multipotent stem cells  [33] 
were  detected  in  spleen  from  day-7  neonate  mice 
(Figure  2A).  Similarly,  we  could  not  detect  C-kit+ 
Sca1+ cells  [34, 35], that are normally present in bone 
marrow, in this population of spleen cells.   
The  morphology  of  these  non-leukocyte  cells 
also resembled the histological prototype of erythro-
cyte precursors. The antigen Ter119 is associated with 
glycophorin A on the surface of immature or matur-
ing erythrocytes  [21], but not blast forming or colony 
forming  units  or  erythro-leukemias.  Therefore,  we 
examined the presence of Ter119+ cells in spleen from 
day-7  neonates.  Mature  peripheral  blood  red  blood 
cells were first lysed from the spleen cell homogenate. 
Interestingly,  we  observed  that  most  of  the 
non-leukocyte population (CD45- cells) was Ter-119+ 
(Figure 2B). Further, these cells did not express the 
markers for the myeloid lineage (Gr1 and CD11b), T 
cell  lineage  (TCR)  or  B  cell  lineage  (B220)  (Figure 
2B). To demonstrate that this population represents 
immature  erythroid  cells  generated  after  birth,  we 
assessed the presence of fetal and adult hemoglobin. 
Ter119+ cells were isolated from day-17 fetal liver and Int. J. Biol. Sci. 2012, 8 
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from the spleen of day-7 neonates. Relative to fetal 
liver Ter119+ cells, almost no expression of fetal he-
moglobin was detected in Ter119 cells from spleen of 
day-7 neonates (Figure 2C). They however expressed 
adult hemoglobin, but to a lower level compared with 
the  fetal  liver  Ter119+  cells  (Figure  2C).  Taken  to-
gether,  these  data  identify  the  accumulation  of  an 
immature erythroid population in the spleen of neo-
nates that is likely not derived from fetal hematopoi-
esis and is generated several days after birth. 
The accumulation of immature erythroid cells 
compromises the presence of lymphocytes in 
spleen of neonates. 
 To more carefully document the kinetics for ac-
cumulation of the immature erythroid cells in neona-
tal spleen over the time of development, we collected 
spleen cells at regular intervals from 2 days after birth 
to 3 weeks after weaning. We further confirmed that a 
major accumulation of these cells in the spleen occurs 
between days 6 and 8 after birth (Figure 3A). There-
after they slowly decreased but even at weaning age 
they comprised a higher proportion of the spleen than 
that found in adult spleen (5 weeks of age). The win-
dow  for  the  accumulation  peak  of  Ter119  cells  in 
spleen and their further disappearance was consistent 
among different littermates and different experiments 
(Fig. 3B). 
 The  expansion  and  contraction  of  a  discreet 
non-lymphoid cell population in the spleen may alter 
the environment for the development of immune cells 
in that tissue, particularly if these cells compete for 
nutrients or other resources. When we examined the 
kinetics  of  other  lymphoid  cell  populations  in  the 
spleen during neonatal life, we found that both CD4 
and CD8 T cells remain a minority population from 
early after birth to weaning age (Figure 3C and 3E). 
The expansion of T cells at this stage correlated with 
the contraction of the nucleated Ter119+ population 
(Figure 3A and 3B). Interestingly, unlike T cells, the B 
cell population is highly represented early after birth 
(days 2-4) (Figure  3D). However, it drastically con-
tracted at day 5-6 after birth in correlation with the 
expansion  of  the  erythroid  cell  population,  and  ex-
panded again- also correlating with the contraction of 
the erythroid cell  population (Figure  3D). Thus the 
transient  but  rapid  accumulation  of  the  immature 
erythroid population compromises and/or limits the 
presence of T and B cells in the spleen in neonates. We 
also  observed  neutrophils  to  be  the  second  (after B 
cells) most abundant cell lineage in spleen early after 
birth  (days  2-4)  as  determined  by  flow  cytometry 
analysis  (Gr1+  CD11b+)  (Figure  3F)  and  by  Giemsa 
staining  (data  not  shown).  The  presence  of  neutro-
phils in the spleen of neonates is rapidly terminated 
with the arrival of the immature erythroid cells. These 
data  further  suggest  that  the  accumulation  of 
erythroid cells in the spleen of neonates may also af-
fect the innate immune system. 
Immature erythroid cells present in the neo-
natal spleen have the ability to regulate acti-
vation and effector function of CD4 T cells.  
 By the current paradigm, CD4 T cell activation 
and differentiation is regulated primarily by antigen 
presenting cells that provide not only the specific an-
tigens  but  also  the  right  cytokine  milieu.  However, 
cells other than immune cells could also contribute to 
shaping CD4 T cell responses if present in sufficient 
amount. Since the data above show the presence of a 
large  frequency  of  immature  erythroid  cells  in  the 
spleen of neonates, these cells could also modulate the 
CD4 T cell response. To test this hypothesis purified 
CD4 T cells from adult mice were activated with an-
ti-CD3 and anti-CD28 monoclonal antibodies (Abs) in 
the  absence  or  presence  of  purified  immature 
erythroid cells (nucleated Ter119+ cells) from spleen of 
day-6  neonates.  After  three  days  of  differentiation, 
CD4 T cells were harvested and extensively washed. 
No Ter119+ cells remained alive at this time (data not 
shown).  Equal  numbers  of  CD4  T  cells  were  then 
re-stimulated with anti-CD3 Ab for 24 hours. Cyto-
kine  levels  in  the  culture  supernatants  were  deter-
mined by ELISA. The presence of Ter119 cells during 
differentiation  prevented  the  production  of  IL-2  by 
effector  CD4  T  cells  (Figure  4A,  top  panel).  The 
Ter119 cells also compromised the production of IFN 
by  effector  CD4  T  cells  (Figure  4A,  middle  panel). 
Since both of these cytokines have been grouped as 
Th1-type cytokines, we also examined IL-4 levels as a 
marker for Th2 effector cells. Interestingly, IL-4 pro-
duction by CD4 T cells differentiated in the presence 
of Ter119+ cells was not reduced but enhanced (Figure 
4A, bottom panel). Since the difference in cytokines in 
the culture supernatants could also be due to an in-
creased or decreased uptake of cytokine, we examined 
cytokine  gene  expression  by  quantitative  reverse 
transcriptase  (RT)-PCR  in  effector  CD4  T  cells  that 
were  differentiated  in  the  presence  or  absence  of 
Ter119+ cells. Correlating with the cytokine levels in 
culture supernatant, Ter119+ cells caused a downreg-
ulation  of  IL-2  and  IFN  gene  expression,  and  an 
up-regulation  of  IL-4  gene  expression  (Figure  4B). 
Thus, the presence of immature erythroid cells during 
the antigen stimulation of CD4 T cells can influence 
the type of cytokine produced as effector cells, with a 
bias towards Th2-type cytokines.  Int. J. Biol. Sci. 2012, 8 
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Figure 3. The accumulation of immature erythroid cells compromises the representation of T and B cells in neonate 
spleens. (A, C, D, E and F) Flow cytometry analysis to determine the relative percentage of Ter119+ cells (A), CD4 T cells (C), CD8 T 
cells (D), B cells (B220) (E) and neutrophil/granulocytes (Gr1) (F) in spleens from mice at different days after birth. Each bar in represents 
the mean of two mice and are representative of 2 experiments. (B) Relative percentages of Ter119+ cells in spleen from mice at 7, 9, 11 
and 21 days after birth. Error bars represent the standard error of the mean of at least four mice per group. Asterisk denotes a statistically 
significant (p <0.05) decrease in the percentage of Ter119+ cells between day 7 and day 9, and between day 9 and 21. Overall significance 
is at p<0.0001. Analyses were performed by ANOVA with Newman-Keuls Multiple comparisons test.  Int. J. Biol. Sci. 2012, 8 
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Figure 4. The presence of Ter119+ cells during the differentiation of CD4 T cells provides a Th2 bias. A. Purified adult 
CD4 T cells (106 cells) were activated with anti-CD3 and anti-CD28 Abs for 3 days in the absence (-) or the presence of 1.5 x105 or 3x 
10 5 Ter119+ cells from day-7 neonatal spleens. Cells were washed and equal number was restimulated with anti-CD3 Ab alone for 24 h. 
Levels of IL-2, IFN, and IL-4 in supernatant were determined by ELISA. B. CD4 T cells were activated and restimulated as in (A) using 1.5 
x105 Ter119+ cells. Relative levels of IL-2, IFN and IL-4 mRNA were determined by real time RT-PCR. Fold induction relative to CD4 
cells activated in the absence of Ter119 cells is shown. Data shown is representative of two experiments. 
 
Immature erythroid cells from neonatal spleen 
secrete IL-6.  
The exogenous cytokine milieu during the dif-
ferentiation  of  naïve  CD4  T  cells  into  effector  cells 
plays  an  important  role  in  determining  the  fate  of 
effector CD4 T cells and the type of cytokines these 
cells subsequently produce.  
IL-4 is the main differentiation factor for Th2 ef-
fector  cells,  but  the  predominant  source  of  IL-4  are 
CD4  T  cells  themselves.  We  have  shown  that  the 
proinflammatory cytokine IL-6 can promote Th2 bias 
by enhancing IL-4 production by CD4 T cells during 
their  differentiation  from  naïve  to  effector  cells 
[36],[37]. Since IL-6 can be produced by a number of 
cells  outside  of  the  immune  system  [38-45],  we  ex-
amined whether IL-4 expression during the differen-
tiation of naïve CD4 T cells was also affected by the 
presence of neonatal immature erythroid cells. Adult 
CD4 T cells were activated in the presence or absence Int. J. Biol. Sci. 2012, 8 
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of nenonatal Ter119+ cells as described above and IL-4 
expression  was  determined  after  3  days  of  culture. 
Increased levels of IL-4 were expressed by CD4 T cells 
activated  in  the  presence  of  Ter119+  cells  for  three 
days (Figure 5A), suggesting that the increased pro-
duction  of  IL-4  during  the  differentiation  was  the 
cause for the Th2 bias observed during restimulation 
(Figure 4). We therefore tested whether Ter119+ cells 
could provide IL-6 to CD4 T cells and in turn promote 
IL-4 production by CD4 T cells. Analysis of IL-6 levels 
in the culture supernatant showed almost undetecta-
ble levels produced by CD4 T cells activated in the 
absence of Ter119+ cells (Figure 5B). However, high 
levels of IL-6 were present in cultures  of CD4 cells 
activated in the presence of Ter119+ cells (Figure 5B).  
 
 
 
Figure 5. Neonate immature erythroid cells produce IL-6 during the co-culture with CD4 T cells. A. Relative IL-4 mRNA 
levels in adult CD4 T cells activated with anti-CD3 and anti-CD28 Abs in the absence (-) or presence (Ter119) of day-7 neonatal spleen 
Ter119+ cells (3x105) for 3 days, determined by real time RT-PCR. B. Purified adult CD4 T cells were activated with anti-CD3 and 
anti-CD28 Abs in the absence (-) or presence of the indicated number of neonatal spleen Ter119+ cells for 2 or 3 days and IL-6 production 
in the supernatant was determined by ELISA. C. Day-6 neonatal spleen Ter119+ cells were incubated in medium alone. Purified adult CD4 
T cells were activated with anti-CD3 and anti-CD28 Abs. After 24 h, relative levels of IL-6 mRNA (left panel) in both cultures were 
determined by real time RT-PCR, and IL-6 production in the culture supernatants (right panel) was determined by ELISA. D. Adult WT 
CD4 T cells were activated with anti-CD3 and anti-CD28 Abs in the presence of Ter119+ cells isolated from WT (WT Ter119) or IL-6 
KO (KO Ter119) day 6-neonates. After 24 h, relative levels of IL-6 mRNA (left panel) in both co-cultures were determined by real time 
RT-PCR, and IL-6 production in the co-culture supernatants (right panel) was determined by ELISA. E. Adult CD4 T cells were activated 
in the absence (-) and presence of Ter119+ cells isolated from WT or IL-6 KO neonates for three days. Cells were washed and res-
timulated with anti-CD3 for 24 h and the relative IL-4 mRNA levels were determined by real time RT-PCR. Data shown is the mean of 
duplicate wells for each assay performed. Int. J. Biol. Sci. 2012, 8 
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To  determine  whether  the  immature  erythroid 
cells could be a source of IL-6, we examined IL-6 gene 
expression in Ter119+ cells cultured alone or CD4 T 
cells cultured alone for one day. Analysis of mRNA 
shows levels of IL-6 mRNA in Ter119 cells substan-
tially  higher  than  in  CD4  T  cells.  (Figure  5C,  left 
panel). Moreover, analysis of IL-6 in culture super-
natants  from  these  cells  by  ELISA  confirmed  that 
Ter119+ cells were able to produce and secrete IL-6 
(Figure 5C, right panel).  
 To further assess the contribution of IL-6 derived 
from the immature erythroid cells to the overall IL-6 
produced  during  the  co-culture  of  these  cells  with 
CD4 T cells we used Ter119+ cells from IL-6 knockout 
(KO) mice. Wildtype (WT) CD4 T cells were activated 
in the presence of Ter119+ cells isolated from spleens 
of  WT  and  IL-6  KO  neonatal  (day  6)  mice.  After 
twenty-four hours in culture, IL-6 mRNA levels were 
three-fold higher in co-cultures of CD4 T cells and WT 
Ter119+ cells as compared to co-cultures with IL-6 KO 
Ter119+ cells (Figure 5D, left panel). Similarly, higher 
levels of IL-6 were found in culture supernatants from 
CD4 T cells activated in the presence of WT Ter119+ 
cells compared with the levels of IL-6 in cultures with 
IL-6 KO Ter119+ cells (Figure 5D, right panel). Thus, 
immature erythroid cells represent the predominant 
source of IL-6 in these cultures. 
Analysis of IL-4 expression upon restimulation 
of effector CD4 T cells from these co-cultures showed 
an upregulation of IL-4 in CD4 T cells that were dif-
ferentiated in the presence of WT Ter119+ cells, but 
not  in  CD4  T  cells  that  were  differentiated  in  the 
presence  of  IL-6  KO  Ter119+  cells  (Figure  5E).  To-
gether, these results demonstrate that the immature 
erythroid cells transiently accumulating in the spleen 
of neonates have the ability to produce IL-6 during 
activation  of  CD4  T  cells  and  the  presence  of  IL-6 
helps to promote a bias towards IL-4 producing ef-
fector CD4 T cells.  
Discussion 
Current thinking is that the immune system of 
the neonate is unique compared to that of adults and 
even older children, and that more sophisticated ap-
proaches must be sought in order to achieve effective 
vaccination  against  exposure  to  infectious  agents  at 
this developmental stage. To that end, we believe the 
maturity or composition of tissues such as the lymph 
nodes and spleen are relevant targets for examination 
with regard to the development of early immunity. It 
is  commonly  known  that  the  neonatal  spleen  is  a 
“unique” or even “odd” organ. However, it is clear 
the spleen plays an important role in immunity [46]. 
In this study, we show that while the first 3-4 days 
after birth B cells and neutrophils seem to be the most 
representative populations, 6-7 days after birth there 
is a rapid and drastic accumulation of large nucleated 
erythroid cells bearing the Ter119 antigen that occupy 
most of the mouse spleen. We reason that the pres-
ence of these cells in the spleen is not likely for the 
purpose  of  prolongation  of  fetal  hematopoiesis  be-
cause the observed accumulation does not take place 
until several days after birth. Moreover we observed 
that their level of fetal hemoglobin is much lower than 
that found in fetal liver and that they express rela-
tively higher amounts of adult hemoglobin.  
Thus, during the life of neonates some kind of 
biological event must take place to trigger this spleen 
recruitment  and/or  expansion  of  these  immature 
erythroid  cells.  These  cells  are  slowly  lost  in  the 
spleen during  maturation  of the neonates and by 4 
weeks of age only 2-3% of spleen cells are represented 
by these Ter119+ cells. It is known that the frequency 
of Ter119+ erythroid cells can also be modulated at the 
adult stage during times of stress, for example infec-
tion  [47,  48].  It  is  likely  that  an  environmental  or 
hormonal factor such as those relating to food intake, 
socialization,  or  sexual  maturation,  influence  the 
presence  of  these  cells.  Recently,  it  was  found  that 
injection of the T cell homeostatic factor IL-7 into mice 
increased erythrocyte precursors directly [49]. More-
over, another T cell homeostatic factor, IL-15 has also 
been shown to effect hematopoiesis [50]. It is possible 
that some of these factors contribute to the accumula-
tion of immature erythroid cells in the spleen of neo-
nates.  
 The  proportional  increase  in  these  immature 
erythroid cells in the neonatal spleen approximately 
one week after birth is associated with a decrease in B 
and T cells. The decrease in the lymphocytic popula-
tions is probably due to the space limitation within 
the spleen, since the erythroid cells occupy most of the 
capacity of this organ. It is also possible that erythroid 
cells may “out compete” T and B cells for the same 
proliferative or homeostatic factors in the process of 
expansion. Histological analysis of spleen from day-6 
neonates showed a disrupted cell distribution with B 
and T cell areas are no longer defined due to the ho-
mogenous  distribution  of  nucleated  erythroid  cells 
(data not shown). The space limitation, disrupted or-
ganogenesis, and possible direct suppression by se-
creted factors [51] might account for the apparently 
impaired  immune  function  reported  in  older  data 
regarding neonates of this age. However, it is clear 
that these obstacles can be relatively overcome, with 
the outcome a skewing of the immune response [9, 10, 
16, 18]. 
We  show  here  for  the  first  time  that  neonatal Int. J. Biol. Sci. 2012, 8 
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immature erythroid cells from the spleen can regulate 
CD4  T  cell  differentiation  and  the  cytokine  pattern 
produced. Our studies show that the presence of these 
neonatal immature erythroid cells during the activa-
tion of CD4 T cells leads to effector cells that produce 
reduced  levels  of  IL-2  and  IFN  (considered  as 
Th1-type of cytokines), but instead produce increased 
levels of IL-4 (the prototype Th2 cytokine). Thus, the 
neonatal  immature  erythroid  cells  can  alter  the 
Th1/Th2 cytokine balance, and these cells may sup-
port a Th2 bias during neonatal development. A po-
tential mechanism by which immature erythroid cells 
can  modulate  the  CD4  T  cell  immune  response  is 
through the secretion of cytokines. Here we show that 
neonatal Ter119+ spleen cells produce IL-6 and that 
this IL-6 contributes to the IL-4 upregulation in CD4 T 
cells when co-cultured. However, we do not rule out 
the participation of alternative mechanisms by which 
neonatal spleen erythroid cells can participate in ef-
fector CD4 T cell differentiation, such as by secretion 
of other cytokines as well as by physical interaction 
(e.g. adhesion molecules) with receptors/ligands on 
CD4  T  cells.  Moreover,  these  studies  do  not  com-
pletely rule out the possible involvement of other cell 
types  that  might  indirectly  mediate  the  effects  of 
Ter119+ cells on CD4 T cells. 
 In summary, we have identified here that neo-
natal immature erythroid cells have an immunomod-
ulatory role in CD4 T cell responses and that the mas-
sive presence of these cells in the spleen, selectively at 
several days after birth, could have a major impact in 
the overall immune response in neonates. Thus, the 
course  of  an  immune  response  during  infection  or 
during vaccination of infants could be influenced by 
the presence of these immature erythroid cells. These 
studies underline the complex nature of the immune 
response in neonates and suggest future studies of the 
effects of Ter119+ cells on the function of other im-
mune cells. 
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